Member Info for HedgeHogarth

4 x 1m buys today...

New soon I expect...

Wise words Saint - this is not the first stck to sufer this fate and wont be the last...
Still everthing to play for here...

Time will tell Dhub whether this goes to 1.5p....
Sorry to hear you have lost £50k
Much will depend on the next moves from hemo on the financing situation, update on CBR and more details of the ongoing partnership with GC.
If news come sooner rather than later, I can also see this moving up very quickly.

Been a hell of a lot of buying and selling in the last week - who knows where we are at with teh supply and demand.

The timing of the recovery will almost certainly take us by surprise....

MrIndia - market and company sentiment, bit of positive PR, and clearly when a seller is finished up their is less supply

@Digitt - my bad. I was thinking the conversions flowed money into Hemo. They dont, they reduce the debt

For anyone disillusioned with the SP - take a look at something like Rambler....

It recently went down to 0.22p due to (1) Funding and (2) A seller (Sound familiar...?)

One the dust settled on he funding and the seller had cleared it's now moved quickly to 0.56p and many are expecting it to go much higher.

I doubt that Hemo have actually spent much of the initial £12m yet. On top of that they have the money form the equity conversions.

Hemo would prefre to move forward without needed to use the Mint funding - so will be looking at ways to avoid taking further tranches and potentially pay back the remaining £9m.

Clearly, in the absence of the Mint funding, Hemo will need a plan B which I'm sure is part of the ongoing negotiations with Global Co and perhaps other third parties.

I agree that there is uncertainty - I'm looking at this glass half full and that Hemo will find a positive way forwards to allow thier science to flourish. If successful, their candidates will be make billions in time.

Good post Stu - it's been a tough few weeks and months as a Hemo investors..

But the market as not only thrown the baby out with the bathwater, it has thrown out the whole bathroom - in short, a massive overreaction

I'm not going to make silly prediction on what the SP may do in the coming days or weeks - but I will confidently say that current prices are a great entry point for genuine investors. Nothing goes up in a straight line....and on the few occasions they do, they often come crashing down..

Surprised to still see some sellers today at these rock bottom prices - Vlad did a great job to re-assure investors that:

(1) The SP reaction and Mint conversions is no more than a short term blip

(2) The company are actively working to bring about a conclusion to the finance that will be mutually benefitial to Mint and Hemogenyx

(3) The Global Co partnership remains in good shape - they did not take the option, but this was not becuase of the science. Vlad alluded to three reasons here - (1) he was not satisfied with the offer from GlobalCo (he does not want to be fobbed off with a pre clinical financial outcome, Hemo investors deserve more) (2) He's not keen to relinquish control of CDX to a GlobalCo with competing priorities and (3) Issues unique to the current position of GlobalCo

(4) He promised an update soon on CBR - previous updates have indicated this is a unique and very encouraging product candidate. Hemo are waiting to get absolute confidence that this can play a genuine role in treating COVID-19. Anyone thinking Hemo have missed the boat and that COVID-19 is over is deluded

(5) CART IND expected Q1 2022 at the latest - but company aiming to get tis sorted by the end of thise year.

The science is very much on track and remains as exciting as ever. The Mint Saga has not been ideal, but Hemo aactively working on a solution. Have no doubt that this time next year CAR T, CDX, and CBR will be in clinical trials.

I've taken the drop in SP as an opportunity to top-up and look forward with a high degree of confidence and optimism .

I'm sure the usual suspects on here will continue to be critical of Hemo and downplay the investment - but ask yourself why. Why spend your life posting to a bulletin board in which you are not invested to critise the company and consistetly try to play on people's fear. You'd think they would have something better to do..... unless of course they are here to encourage investors to sell and prospective investors to look elsewhere.....Food for though - hey....

A few months in the life of a stock is nothing - for all those buying at sub 10p, just think how much this could be worth in 2 years which is a more realistic Investors horizon....

GLA

Staggers me some of the comments on here - investing would be easy we if were all assured that the shares we were buying that were on an upward trajectory

Fascinating to see the MM manipulation....
Super tight spread, small dummy buys to try and make the big buys look like sells....
I genuinely believe we are at bargain basement right now

There is risk and reward with every share.
If you think the market would put a value of sub £10m on this stock - i.e. 2p a share - Don't invest, simple as that
I happen to still value this company signifcantly higher than today's MCAP of £17m

Interview is this week i believe

Hemo has £60m finance facility - so i dont see it running out of money
I'm also pretty confident it has IP / value in its pre clinical assets that suggest very little risk at tis SP
A Global Co would snap up the company at £20m in a heartbeat...

Its not exactly dropping like a stone now - the damage is done.

The next genuine movement will be defined by the next RNS and developments coming from the company.

I'm keen for an update on CDX, funding and CBR

Clearly, i'd prefer the SP to be higher, but i have no intent to sell my shares. If anything, the investmest is now largely de-risked at this low MCAP. ONwards and upwards.

@Pumpky

Another ridiculous comment. Are you suggesting all the work that Vlad and his team are doing toward finding a cure for cancer and automimmune diseases is either a hoax or dommed to fail?

Maybe the science will untilmately prove unsuccessful, but you and I do not know that now and Hemo are well placed to take a number of game changing clinical candidates into trials. If 1 or more come off, i think you'll find Vlad has earned his corn many times over....

Usual depressing rubbish from CJ Sterling...
Are you suggesting Vlad should not get paid that much? I get paid that much and Vlad is smarter thatn me.

Good luck Dhub - you made me chuckle ;-)

If i had to guess this is a CLN conversion facilitated between Hemo and Mint to support a tird party taking a share in the business.

It would provide Mint with some margin, and support a deal that hemo could be working on

I'm only guessing